Index
RUT
Market Cap
2.37B
Enterprise Value
2.32B
Income
21.46M
Sales
292.09M
Book/sh
6.98
Cash/sh
2.85
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
398
IPO
Feb 04, 1997
P/E
113.28
Forward P/E
52.84
PEG
0.85
P/S
8.10
P/B
6.63
P/C
16.28
P/FCF
49.82
EV/EBITDA
83.05
EV/Sales
7.93
Quick Ratio
4.79
Current Ratio
5.18
Debt/Eq
0.27
LT Debt/Eq
0.23
Option/Short
Yes / Yes
EPS (ttm)
0.41
EPS next Y
0.88
EPS next Q
-0.03
EPS this Y
47.52%
EPS next Y
85.75%
EPS next 5Y
62.51%
EPS past 3/5Y
- 39.20%
Sales past 3/5Y
18.90% 17.34%
EPS Y/Y TTM
602.15%
Sales Y/Y TTM
22.45%
EPS Q/Q
44.94%
Sales Q/Q
30.09%
Insider Own
1.21%
Insider Trans
-20.17%
Inst Own
108.87%
Inst Trans
2.71%
ROA
4.72%
ROE
6.59%
ROIC
4.89%
Gross Margin
74.84%
Oper. Margin
5.40%
Profit Margin
7.35%
SMA20
14.83%
SMA50
25.58%
SMA200
28.96%
Trades
Shs Outstand
51.01M
Shs Float
50.45M
52W High
46.62 -0.62%
52W Low
28.95 60.03%
Volatility
5.08% 4.52%
ATR (14)
1.73
RSI (14)
76.01
Beta
1.07
Rel Volume
0.37
Avg Volume
656.83K
Volume
144,106
Perf Week
8.00%
Perf Month
34.48%
Perf Quarter
42.29%
Perf Half Y
26.14%
Perf YTD
28.66%
Perf Year
11.75%
Perf 3Y
23.32%
Perf 5Y
-10.51%
Perf 10Y
1950.00%
Prev Close
45.15
Price
46.33
Change
2.61%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-17-25 Downgrade BTIG Research
Buy → Neutral
Aug-09-24 Initiated Canaccord Genuity
Buy
$57
Jun-20-24 Initiated TD Cowen
Buy
$55
Jan-25-24 Upgrade Truist
Hold → Buy
$39 → $51
Aug-08-23 Upgrade BTIG Research
Neutral → Buy
$39
Nov-10-22 Downgrade BTIG Research
Buy → Neutral
Nov-09-22 Downgrade Truist
Buy → Hold
Oct-14-22 Resumed Stephens
Overweight
$40
Jan-11-21 Downgrade Oppenheimer
Outperform → Perform
Dec-18-20 Initiated Stephens
Overweight
$31
Sep-17-20 Initiated Truist
Buy
$24
Oct-09-19 Initiated H.C. Wainwright
Buy
$19
Feb-28-19 Downgrade Needham
Buy → Hold
Aug-08-18 Reiterated Needham
Buy
$15 → $14
Jul-16-18 Upgrade Ladenburg Thalmann
Neutral → Buy
Apr-04-18 Initiated Leerink Partners
Outperform
$15
Mar-06-18 Reiterated Needham
Buy
$5 → $15
Mar-06-18 Downgrade Ladenburg Thalmann
Buy → Neutral
Mar-05-18 Reiterated BTIG Research
Buy
$8 → $13
Jun-21-17 Initiated BTIG Research
Buy
$6
Show Previous Ratings
Today 08:48AM
Jun-09-26 08:30AM
May-07-26 07:45AM
Apr-23-26 08:30AM
Apr-02-26 02:40PM
08:31PM
Loading…
Mar-09-26 08:31PM
Mar-04-26 08:00AM
Mar-03-26 08:30AM
Feb-28-26 08:05PM
Feb-27-26 12:39PM
Feb-26-26 08:09PM
04:11PM
12:15PM
07:55AM
Feb-12-26 08:30AM
12:57PM
Loading…
Jan-13-26 12:57PM
09:00AM
Jan-06-26 08:30AM
Dec-21-25 09:57AM
Nov-14-25 08:30AM
Nov-10-25 09:55AM
Nov-06-25 04:01PM
09:10AM
07:55AM
Oct-31-25 09:15AM
Oct-23-25 08:30AM
Oct-22-25 08:48AM
Oct-20-25 11:08PM
Sep-12-25 08:53AM
Sep-11-25 03:46PM
08:30AM
Loading…
Aug-28-25 08:30AM
Aug-20-25 12:13AM
Jul-31-25 09:15AM
08:08AM
Jul-30-25 09:44AM
09:00AM
Jul-24-25 09:47AM
Jul-17-25 08:30AM
Jun-10-25 08:30AM
May-09-25 03:13AM
May-08-25 09:05AM
08:45AM
07:55AM
May-07-25 02:18PM
10:08AM
08:30AM
May-06-25 05:35PM
May-01-25 05:15PM
Apr-30-25 08:39AM
Apr-24-25 08:30AM
Mar-04-25 08:30AM
Feb-28-25 02:11AM
01:51AM
(Thomson Reuters StreetEvents)
Feb-27-25 09:05AM
07:54AM
Feb-26-25 07:28AM
Feb-13-25 08:30AM
Jan-14-25 04:05PM
Jan-08-25 08:30AM
Dec-19-24 07:36AM
Nov-11-24 02:06PM
(Investor's Business Daily)
+5.15%
Nov-08-24 04:03AM
Nov-07-24 09:10AM
07:55AM
Nov-06-24 07:15AM
Oct-24-24 08:30AM
Oct-22-24 09:31AM
Oct-18-24 03:04PM
Oct-09-24 03:44PM
Aug-29-24 09:17AM
Aug-26-24 07:45AM
Aug-16-24 10:33AM
Aug-15-24 04:05PM
Aug-07-24 08:30AM
Aug-05-24 12:00PM
Aug-01-24 09:05AM
07:55AM
Jul-29-24 03:45PM
Jul-22-24 08:30AM
Jul-18-24 08:30AM
Jul-16-24 07:01PM
Jul-02-24 09:58AM
Jun-27-24 02:03PM
Jun-25-24 07:22AM
Jun-20-24 09:54AM
Jun-11-24 08:30AM
May-22-24 08:30AM
May-21-24 06:42AM
May-09-24 03:28PM
03:08AM
May-08-24 11:24PM
(Thomson Reuters StreetEvents)
09:35AM
09:10AM
07:55AM
Apr-24-24 08:30AM
Mar-29-24 07:01PM
Mar-28-24 01:48PM
(Investor's Business Daily)
Mar-15-24 07:00PM
Mar-01-24 09:30AM
Feb-29-24 11:37PM
(Thomson Reuters StreetEvents)
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
CEO Mr. Dominick C. Colangelo Esq.
CFO & Treasurer Mr. Joseph Anthony Mara Jr.
Chief Operating Officer Mr. Michael Halpin
Chief Legal Officer Mr. Sean C. Flynn
M.B. Ch.B. Dr. Jonathan M. Hopper FRCSEd.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SIEGAL JONATHAN Principal Accounting Officer Jun 26 '26 Option Exercise 29.82 2,500 74,550 3,386 Jun 30 04:05 PM SIEGAL JONATHAN Principal Accounting Officer Jun 26 '26 Sale 44.90 2,732 122,667 886 Jun 30 04:05 PM Mara Joseph Anthony Jr Chief Financial Officer Jun 26 '26 Sale 44.75 5,000 223,750 16,009 Jun 30 04:05 PM Hopper Jonathan Mark Chief Medical Officer Jun 26 '26 Option Exercise 29.82 10,000 298,200 80,753 Jun 30 04:05 PM Hopper Jonathan Mark Chief Medical Officer Jun 26 '26 Sale 45.00 10,000 450,000 75,753 Jun 30 04:05 PM Flynn Sean C. Chief Legal Officer Jun 26 '26 Option Exercise 16.25 15,000 243,750 16,647 Jun 30 04:05 PM Flynn Sean C. Chief Legal Officer Jun 26 '26 Sale 45.64 15,000 684,600 1,647 Jun 30 04:05 PM Flynn Sean C. Officer Jun 26 '26 Proposed Sale 45.64 15,000 684,659 Jun 26 04:21 PM Mara Joseph Anthony Jr Officer Jun 26 '26 Proposed Sale 44.75 5,000 223,750 Jun 26 04:12 PM SIEGAL JONATHAN Officer Jun 26 '26 Proposed Sale 44.90 2,732 122,667 Jun 26 04:02 PM Hopper Jonathan Mark Officer Jun 26 '26 Proposed Sale 45.00 10,000 450,000 Jun 26 03:55 PM Halpin Michael Chief Operating Officer Jun 18 '26 Option Exercise 16.66 10,000 166,600 26,248 Jun 22 04:05 PM Halpin Michael Chief Operating Officer Jun 18 '26 Sale 40.24 10,000 402,400 16,248 Jun 22 04:05 PM Flynn Sean C. Chief Legal Officer Jun 18 '26 Option Exercise 16.25 15,000 243,750 16,647 Jun 22 04:05 PM Flynn Sean C. Chief Legal Officer Jun 18 '26 Sale 40.21 15,000 603,150 1,647 Jun 22 04:05 PM Flynn Sean C. Officer Jun 18 '26 Proposed Sale 40.21 15,000 603,148 Jun 18 04:26 PM Halpin Michael Officer Jun 18 '26 Proposed Sale 40.24 10,000 402,401 Jun 18 04:11 PM Hopper Jonathan Mark Chief Medical Officer Jun 02 '26 Option Exercise 16.66 4,375 72,888 80,128 Jun 04 04:05 PM Hopper Jonathan Mark Chief Medical Officer Jun 02 '26 Sale 35.00 4,375 153,125 75,753 Jun 04 04:05 PM Hopper Jonathan Mark Officer Jun 02 '26 Proposed Sale 35.00 4,375 153,125 Jun 02 02:40 PM MCLAUGHLIN KEVIN F Director May 13 '26 Option Exercise 7.84 7,000 54,880 21,800 May 15 04:06 PM MCLAUGHLIN KEVIN F Director May 13 '26 Sale 32.83 7,000 229,775 18,300 May 15 04:06 PM Wotton Paul K Director May 11 '26 Sale 32.74 10,000 327,425 18,802 May 13 04:05 PM MCLAUGHLIN KEVIN F Director May 13 '26 Proposed Sale 32.57 7,000 227,990 May 13 02:16 PM Wotton Paul K Director May 11 '26 Proposed Sale 32.74 10,000 327,425 May 11 02:32 PM Mara Joseph Anthony Jr Chief Financial Officer May 07 '26 Sale 40.50 5,000 202,500 21,009 May 08 04:05 PM SIEGAL JONATHAN Principal Accounting Officer May 06 '26 Sale 38.00 3,433 130,454 2,540 May 08 04:05 PM SIEGAL JONATHAN Principal Accounting Officer May 07 '26 Sale 40.50 1,422 57,591 1,118 May 08 04:05 PM SIEGAL JONATHAN Officer May 07 '26 Proposed Sale 40.50 1,422 57,591 May 07 12:36 PM Mara Joseph Anthony Jr Officer May 07 '26 Proposed Sale 40.50 5,000 202,500 May 07 12:02 PM SIEGAL JONATHAN Officer May 06 '26 Proposed Sale 38.00 3,433 130,454 May 06 03:30 PM Hopper Jonathan Mark Chief Medical Officer Apr 02 '26 Option Exercise 10.95 3,472 38,018 79,028 Apr 06 04:05 PM Hopper Jonathan Mark Chief Medical Officer Apr 02 '26 Sale 35.00 3,472 121,520 75,556 Apr 06 04:05 PM Hopper Jonathan Mark Officer Apr 02 '26 Proposed Sale 35.00 3,472 121,520 Apr 02 02:28 PM Rubino Alan L Director Mar 25 '26 Option Exercise 2.76 15,000 41,400 60,994 Mar 27 04:05 PM Hagen Heidi Director Mar 23 '26 Option Exercise 2.76 15,000 41,400 46,850 Mar 25 04:05 PM Hagen Heidi Director Mar 23 '26 Sale 32.41 15,000 486,150 31,850 Mar 25 04:05 PM Hagen Heidi Director Mar 23 '26 Proposed Sale 32.41 15,000 486,163 Mar 23 04:08 PM Flynn Sean C. Chief Legal Officer Mar 02 '26 Option Exercise 16.25 15,000 243,750 16,262 Mar 04 04:05 PM Flynn Sean C. Chief Legal Officer Mar 02 '26 Sale 35.18 21,421 753,530 1,262 Mar 04 04:05 PM Halpin Michael Chief Operating Officer Mar 02 '26 Sale 35.30 10,305 363,766 16,080 Mar 04 04:05 PM Flynn Sean C. Officer Mar 02 '26 Proposed Sale 35.18 21,421 753,509 Mar 02 04:54 PM Halpin Michael Officer Mar 02 '26 Proposed Sale 35.30 10,305 363,749 Mar 02 04:21 PM Colangelo Dominick President and CEO Feb 24 '26 Option Exercise 0.00 18,250 0 321,270 Feb 26 04:05 PM Hopper Jonathan Mark Chief Medical Officer Feb 24 '26 Option Exercise 0.00 4,650 0 76,192 Feb 26 04:05 PM SIEGAL JONATHAN Principal Accounting Officer Feb 24 '26 Option Exercise 0.00 3,415 0 6,585 Feb 26 04:05 PM Mara Joseph Anthony Jr Chief Financial Officer Feb 24 '26 Option Exercise 0.00 9,250 0 27,262 Feb 26 04:05 PM Halpin Michael Chief Operating Officer Feb 24 '26 Option Exercise 0.00 10,500 0 28,871 Feb 26 04:05 PM Flynn Sean C. Chief Legal Officer Feb 24 '26 Option Exercise 0.00 6,500 0 9,014 Feb 26 04:05 PM Colangelo Dominick President and CEO Feb 18 '26 Option Exercise 0.00 11,700 0 290,427 Feb 20 04:06 PM Flynn Sean C. Chief Legal Officer Feb 18 '26 Option Exercise 0.00 5,325 0 5,097 Feb 20 04:06 PM Hopper Jonathan Mark Chief Medical Officer Feb 18 '26 Option Exercise 0.00 2,325 0 72,009 Feb 20 04:06 PM Mara Joseph Anthony Jr Chief Financial Officer Feb 18 '26 Option Exercise 0.00 7,380 0 20,179 Feb 20 04:06 PM SIEGAL JONATHAN Principal Accounting Officer Feb 18 '26 Option Exercise 0.00 2,920 0 4,682 Feb 20 04:06 PM Halpin Michael Chief Operating Officer Feb 18 '26 Option Exercise 0.00 9,075 0 22,669 Feb 20 04:06 PM MCLAUGHLIN KEVIN F Director Feb 11 '26 Option Exercise 2.63 7,000 18,410 22,100 Feb 13 04:05 PM MCLAUGHLIN KEVIN F Director Feb 11 '26 Sale 34.66 7,000 242,620 15,100 Feb 13 04:05 PM MCLAUGHLIN KEVIN F Director Feb 11 '26 Proposed Sale 35.62 7,000 249,340 Feb 11 10:07 AM Halpin Michael Chief Operating Officer Jan 07 '26 Option Exercise 16.66 10,000 166,600 26,080 Jan 09 04:05 PM Halpin Michael Chief Operating Officer Jan 07 '26 Sale 40.48 10,000 404,800 16,080 Jan 09 04:05 PM Halpin Michael Officer Jan 07 '26 Proposed Sale 40.48 10,000 404,833 Jan 07 04:22 PM Mahoney Karen Chief Human Resources Officer Jul 22 '25 Option Exercise 0.00 2,625 0 2,625 Dec 12 04:05 PM Hopper Jonathan Mark Chief Medical Officer Dec 02 '25 Option Exercise 18.00 1,652 29,736 68,214 Dec 04 04:05 PM Hopper Jonathan Mark Chief Medical Officer Dec 02 '25 Sale 39.14 1,652 64,659 66,562 Dec 04 04:05 PM Wotton Paul K Director Dec 02 '25 Sale 37.97 2,500 94,925 28,102 Dec 04 04:05 PM Wotton Paul K Director Dec 03 '25 Sale 37.83 2,500 94,575 25,602 Dec 04 04:05 PM Wotton Paul K Director Dec 03 '25 Proposed Sale 37.83 2,500 94,575 Dec 03 11:25 AM Wotton Paul K Director Dec 02 '25 Proposed Sale 37.97 2,500 94,919 Dec 02 04:08 PM Hopper Jonathan Mark Officer Dec 02 '25 Proposed Sale 39.14 1,652 64,659 Dec 02 10:10 AM Halpin Michael Chief Operating Officer Nov 11 '25 Option Exercise 16.66 2,642 44,016 18,574 Nov 13 04:05 PM Halpin Michael Chief Operating Officer Nov 11 '25 Sale 40.41 2,642 106,763 15,932 Nov 13 04:05 PM MCLAUGHLIN KEVIN F Director Nov 10 '25 Option Exercise 2.63 7,000 18,410 22,100 Nov 12 04:06 PM MCLAUGHLIN KEVIN F Director Nov 10 '25 Sale 38.59 7,000 270,130 15,100 Nov 12 04:06 PM Halpin Michael Officer Nov 11 '25 Proposed Sale 40.41 2,642 106,760 Nov 12 07:33 AM Halpin Michael Chief Operating Officer Nov 06 '25 Option Exercise 16.66 7,358 122,584 23,290 Nov 10 04:05 PM Halpin Michael Chief Operating Officer Nov 06 '25 Sale 40.47 7,358 297,778 15,932 Nov 10 04:05 PM MCLAUGHLIN KEVIN F Director Nov 10 '25 Proposed Sale 39.71 7,000 277,970 Nov 10 02:47 PM Halpin Michael Officer Nov 06 '25 Proposed Sale 40.47 7,358 297,775 Nov 06 04:19 PM SIEGAL JONATHAN Principal Accounting Officer Sep 30 '25 Option Exercise 0.00 938 0 2,440 Oct 02 04:05 PM Hopper Jonathan Mark Chief Medical Officer Sep 02 '25 Option Exercise 18.00 10,000 180,000 76,363 Sep 03 04:06 PM Hopper Jonathan Mark Chief Medical Officer Sep 02 '25 Sale 35.77 10,000 357,700 66,363 Sep 03 04:06 PM Hopper Jonathan Mark Officer Sep 02 '25 Proposed Sale 35.77 10,000 357,700 Sep 02 12:14 PM MCLAUGHLIN KEVIN F Director Aug 06 '25 Option Exercise 2.76 7,000 19,320 22,100 Aug 08 04:05 PM MCLAUGHLIN KEVIN F Director Aug 06 '25 Sale 35.92 7,000 251,440 15,100 Aug 08 04:05 PM MCLAUGHLIN KEVIN F Director Aug 06 '25 Proposed Sale 35.92 7,000 251,457 Aug 06 05:18 PM
